Today, we’re excited to announce the publication of a landmark paper in the leading journal “Cell” from SRF-funded researcher Dr. Howard Chang, Dr. Bingfei Yu, and Dr. Chang’s group at...
Read More
Did you know that artificial intelligence (AI) could help improve scleroderma treatments? SRF-funded investigator Dr. Michael Whitfield has been working for many years to develop a classifier via an artificial...
Read More
Kheesa’s scleroderma symptoms started in 2005. She received her diagnosis two years later, after the birth of her first child. Now she's a mother of two. “They are the achievement...
Read More
February is Black History Month, and Sydney (@sydneysnoble) is spreading awareness about how scleroderma affected her. "I find it extremely important to share my story this month,“ she says. She...
Read More
This Raynaud’s Awareness Month we asked you to share your personal stories, tips, or life hacks with us, and we’ve been blown away by the response! Today, we’re spotlighting three…
One way investigators approach understanding scleroderma is to examine the disease at the cellular level. SRF-funded researcher Dr. Howard Chang and his group recently published a single-cell epigenetic analysis of...
Read More
Like many scleroderma patients, Rose's first clue that eventually led to a scleroderma diagnosis was Raynaud's Phenomenon. As a freshman in college, she initially thought that her hands were hurting...
Read More
Please join us in congratulating SRF Scientific Advisor, Dan Kastner, MD, PhD, who has been awarded this year's Crafoord Prize in Polyarthritis by the Royal Swedish Academy of Sciences. He...
Read More
Scleroderma research isn't one size fits all–each investigator approaches it from a specific angle. For Dr. Zsuzsanna McMahan of the Johns Hopkins University School of Medicine, this means focusing her...
Read More
Lack of awareness about scleroderma causes delays in treatment or misdiagnosis. This must end. At the SRF, we are committed to shining a spotlight on this disease. Patients like David…
